TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Scathing FTC Interim Report on PBMs Warrants Further Investigations, Immediate Action by Policymakers and Regulators
July 09, 2024 13:13 ET
|
National Community Pharmacists Association
Alexandria, Va., July 09, 2024 (GLOBE NEWSWIRE) -- The interim report published today by the Federal Trade Commission – titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs...
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
June 06, 2024 09:00 ET
|
Tiziana Life Sciences Ltd.
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months.FDA...
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
June 03, 2024 08:14 ET
|
AUROBAC THERAPEUTICS
AUROBAC THERAPEUTICS to advance ATX101 in septic shock, and multiple preclinical and discovery programs targeting Gram-negative pathogens. Lyon (France), June 3, 2024 AUROBAC THERAPEUTICS, a...
Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients
May 16, 2024 17:29 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research Launches the Coalition for Clinical Trial Equity to Address Barriers Faced by Black Patients
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
NH Community Health Worker (CHW) Summit Convenes on April 30
April 22, 2024 09:13 ET
|
North Country Health Consortium
Littleton, NH, April 22, 2024 (GLOBE NEWSWIRE) -- Over 150 Community Health Workers (CHWs), healthcare providers, social workers, policymakers, and state agencies will come together on April 30,...
NH Nonprofit Heralds New Research Documenting Community Healthcare Workers
April 03, 2024 14:00 ET
|
North Country Health Consortium
Littleton, NH, April 03, 2024 (GLOBE NEWSWIRE) -- North Country Health Consortium, the New Hampshire nonprofit tasked by state officials to increase awareness and access to Community Healthcare...
Local Pharmacies on the Brink, New Survey Reveals
February 27, 2024 13:27 ET
|
National Community Pharmacists Association
Alexandria, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- As rumors swirl in Washington, D.C., that lawmakers may once again be punting on PBM reform, the National Community Pharmacists Association today...
Community Health Worker (CHW) Initiative Launched In New Hampshire
February 26, 2024 04:00 ET
|
North Country Health Consortium
Littleton, NH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The state of New Hampshire has provided funding to North Country Health Consortium (NCHC) to spearhead a statewide initiative to increase access to...